A SERM increasing the expression of the osteoblastogenesis and mineralization-related proteins and improving quality of bone tissue in an experimental model of osteoporosis

Raloxifene is an antiresorptive drug, selective estrogen receptor modulator (SERM) used in the treatment of osteoporosis. OBJECTIVE: To evaluate proteins related to bone repair at the peri-implant bone in a rat model of osteoporosis treated with raloxifene. MATERIAL AND METHODS: 72 rats were divided...

Descripción completa

Detalles Bibliográficos
Autores principales: Yogui, Fernanda Costa, Momesso, Gustavo Antonio Correa, Faverani, Leonardo Perez, Polo, Tarik Ocon Braga, Ramalho-Ferreira, Gabriel, Hassumi, Jaqueline Suemi, Rossi, Ana Cláudia, Freire, Alexandre Rodrigues, Prado, Felippe Bevilacqua, Okamoto, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade De Odontologia De Bauru - USP 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933824/
https://www.ncbi.nlm.nih.gov/pubmed/29742257
http://dx.doi.org/10.1590/1678-7757-2017-0329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933824/
https://www.ncbi.nlm.nih.gov/pubmed/29742257
http://dx.doi.org/10.1590/1678-7757-2017-0329

Ejemplares similares